SynaptixBio Stock

SynaptixBio is a biotechnology research company that develops lifesaving therapies for severe leukodystrophies.

Sign up today and learn more about SynaptixBio Stock

Invest in or value your shares in one or many pre-IPO companies through an EquityZen investment vehicle.

About SynaptixBio Stock

SynaptixBio is developing lifesaving therapies for severe leukodystrophies. The company enables the translation of ground-breaking research in TUBB4a Leukodystrophy into a transformative therapy. Their updated news is imported into the website. The customer queries are addressed through an online form.

Funding History

April 2023$11.1M


Founder & Board Member

Bent Jakobsen

CEO, Executive Director and Co-founder

Dan Williams

Chief Scientific Officer, Founding Executive Director and Co-Founder

Michelle Teng


Join 630,000+ Investors and Shareholders

On our trusted digital marketplace for private companies

EquityZen Recognized As: